BioCentury | Oct 24, 2019
Preclinical News

Oct. 24 Preclinical Quick Takes: anti-neuraminidase human antibodies for broad flu protection; plus Ionis-Baylor, Merck and more

...capable of inducing immunity across viral subtypes (see “The Universe of Universal Flu Vaccines” ). RICTOR-targeting...
...NASDAQ:IONS) and Baylor College of Medicine team has developed an antisense oligonucleotide (ASO) therapy against RICTOR...
...9; PTEN (MMAC1; TEP1) - Phosphatase and tensin homolog deleted on chromosome ten; RICTOR - Rapamycin-insensitive companion of mTOR...
BioCentury | Feb 5, 2009
Distillery Therapeutics

Indication: Cancer

...Publication and contact information Cancer Prostate cancer Mammalian target of rapamycin (mTOR; FRAP; RAFT1); rapamycin-insensitive companion of mTOR (RICTOR...
...A study in mice suggests that inhibiting mTOR complex 2 (mTORC2), which contains mTOR and RICTOR...
...shRNA (p=0.01). In tumor-developing PTEN+/- mice, those with Rictor+/- had significantly higher one-year survival than Rictor+/+...
Items per page:
1 - 2 of 2